Journal club: STEP 1 and the treatment-policy estimand — does this still hold?
The question underneath STEP 1 is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it.
Write down what you would expect to see under each hypothesis before you collect anything. If they predict the same observation, collecting it will not help.
I had written a reply contradicting post #40 and deleted it. Here is what survived.
Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
I would rather say I do not know than round it up to an answer.
Post #46 answers the question as asked. The question underneath it is different.
Adding the boring version of STEP 1, because the interesting version keeps getting posted and the boring one is usually right.
Check the ordinary explanations, in order, and stop when one of them accounts for what you are seeing. Most of the time the second one does.
The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.
Caveat: everything above assumes the paperwork is what it says it is.
STEP 1 is a question about a distribution, not about a value, and treating it as a value is what produces the confident wrong answers.
STEP 1 is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.
Read the full topic (77 posts)
This topic was referenced in
- Journal club: SELECT, absolute risk, and how it was reportedEvidence › Journal club · 2 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Journal club: FLOW and the renal composite, component by component
On the subject in the title: Journal club: FLOW and the renal composite, component by component Working notes rather than a conclusion. Reading FLOW ( N Engl J Med , 2024) for the population rather than the…
|
+84 | 91 | 18k | 2y |
|
Journal club: STEP-HFpEF and symptom endpoints — a second dataset
On the subject in the title: Journal club: STEP-HFpEF and symptom endpoints — a second dataset Working notes rather than a conclusion. Posting a small dataset on step-hfpef and symptom endpoints. It is mine,…
|
+11 | 15 | 4k | 10mo |
|
Journal club: PIONEER 6 as a safety trial
Posting this under the heading it deserves: Journal club: PIONEER 6 as a safety trial Everything below is what sits behind that. Reading PIONEER 6 ( N Engl J Med , 2019) for the population rather than the…
|
+14 | 18 | 262 | 5mo |
|
Journal club: LEADER as the historical anchor
Journal club: LEADER as the historical anchor Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of LEADER is wrong? I ask because I have…
|
+103 | 110 | 8.1k | 2h |
|
Journal club: SUSTAIN 6 and its retinopathy signal
On the subject in the title: Journal club: SUSTAIN 6 and its retinopathy signal Working notes rather than a conclusion. Reading SUSTAIN 6 ( N Engl J Med , 2016) for the population rather than the effect,…
|
+110 | 122 | 46k | 1d |
Related topics — sharing the tags randomised trial, risk of bias, effect size
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Criticising the method without criticising the authors
Criticising the method without criticising the authors Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about criticising the method without criticising in a…
|
+55 | 61 | 60k | 15mo |
|
How to read a forest plot, properly, from scratch
The question in the title: How to read a forest plot, properly, from scratch I will give what I have already checked below so nobody repeats it. Reading STEP 4 ( JAMA , 2021) for the population rather than…
|
+73 | 81 | 17k | 7mo |
|
SURPASS-2 and the comparator dose question that will not go away
SURPASS-2 and the comparator dose question that will not go away — setting out what I have, and where I think it stops being reliable. A methods question rather than a substantive one, about SURPASS-2.…
|
+101 | 111 | 1.5k | 18mo |
|
Coming back to: Prediction intervals and why they are more honest than confidence intervals
Prediction intervals and why they are more honest than confidence intervals Writing it up because I had to work it out twice and would rather nobody else did. Prediction intervals — I have the observation and…
|
2 | 65 | 22mo | |
|
Revisiting: Primary endpoint hierarchies and why order matters
Posting this under the heading it deserves: Revisiting: Primary endpoint hierarchies and why order matters Everything below is what sits behind that. I was wrong about Primary endpoint hierarchies in a thread…
|
+21 | 25 | 46k | 3mo |